According to IMARC Group’s latest report, titled “Angioplasty Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global angioplasty balloons market size reached US$ 2.3 Billion in 2021. Angioplasty balloons are inflated tipped catheters that are used to increase the flow of blood to the heart. These balloons are manufactured from materials such as nylon, polyurethane, and silicone urethane polymers and are available in normal, drug-eluting, scoring, and cutting balloon form. In recent years, angioplasty balloons have gained traction as they facilitate healthcare professionals and doctors to perform surgical procedures and open up the clogged blood vessel during an angioplasty procedure.
Request for a PDF sample of this report: https://www.imarcgroup.com/angioplasty-balloons-market/requestsample
The global angioplasty balloons market is primarily driven by the rising instances of obesity and high cholesterol levels. Besides this, the increasing use of angioplasty balloons in treating coronary and periphery artery diseases is also fueling market growth. In addition to this, the growing consciousness regarding minimally invasive (MI) procedures among people has increased the demand for drug-coated angioplasty balloons offering enhanced safety, effectiveness, and improved blood flow throughout the body. As a result, healthcare professionals increasingly prefer angioplasty balloons to treat artery disorders. Furthermore, research and development (R&D) activities in the field of medical science coupled with technological advancements, such as the introduction of imaging technology and angioplasty balloons that can be implanted without administering anesthesia, are also creating a positive outlook for the market. Looking forward, IMARC Group expects the global angioplasty balloons market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.4% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=2270&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Braun Melsungen AG
- BD (Becton, Dickinson, and Company)
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Endocor GmbH & Co. KG
- Johnson & Johnson
- Medtronic Inc.
- Terumo Corporation
Breakup by Product Type:
- Normal Balloons
- Cutting Balloons
- Drug Eluting Balloons
- Scoring Balloons
Breakup by Application:
- Coronary Angioplasty
- Peripheral Angioplasty
Breakup by Material:
- Silicone Urethane Co-Polymers
Breakup by End-User:
- Ambulatory Surgery Centers
Breakup by Region:
- North America
- United States
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/angioplasty-balloons-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800